Trial Profile
A Phase I Study of the Safety and Pharmacokinetics of Recombinant CD4 (rCD4) in Infants and Children Infected With or at Risk for HIV Infection
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 21 Jul 2022
Price :
$35
*
At a glance
- Drugs CD4 IgG (Primary)
- Indications HIV infections
- Focus Pharmacokinetics
- 24 Oct 2014 New trial record